SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.200+3.9%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NASDBULL who wrote (1061)11/5/1998 10:33:00 PM
From: scaram(o)uche  Read Replies (1) of 3576
 
You can believe whatever you like. Haven't been short any issue for at least four or five years. I have had a long position in GERN once, for about 5 minutes. Did well.

GERN is currently, after today and IMO, over-valued relative to most other third-tier companies.

These are my opinions, and, guess what!!!.... I know more about both the sector and the science than you do.

>> This finding is mindboggling and HUGE, I don't think you understand the ramifications of this finding. GERN will make a significant amount of money in licensing alone.....the thought of the long-term prospects for GERN are immense. <<

We're largely agreed here, except for the understanding the ramifications part. Just one slight modification...... it's the "long-term" that's mindboggling.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext